References
Anisimova EI, Danilov AB. Bendotiamine efficacy
in alcoholic polyneuropathy therapy. Zh Nevrol Psikhiatr Im S S
Korsakova. 2001;101(12):32–6.
Bhatt HR, Linnell JC, et al. Can faulty vitamin B-12 (cobalamin)
metabolism produce diabetic neuropathy? Lancet. 1983 Sep 3;2(8349):572.
Cameron NE, Cotter MA, et al. Effects of alpha-lipoic acid on
neurovascular function in diabetic rats: Interaction with essential
fatty acids. Diabetologia. 1998 Apr;41(4):390–9.
Cunnane SC, Horrobin DF, et al. Essential fatty acids in tissue
phospholipids and triglycerides of the zinc-deficient rat. Proc Soc Exp
Biol Med. 1984a Dec;177(3):441–6.
Cunnane SC, Keeling PW, et al. Linoleic acid and arachidonic acid
metabolism in human peripheral blood leucocytes: Comparison with the
rat. Br J Nutr. 1984b Mar;51(2):209–17.
Cunnane SC, Manku MS, et al. Accumulation of linoleic and
gamma-linolenic acids in tissue lipids of pyridoxine-deficient rats. J
Nutr. 1984c Oct;114(10):1754–61.
Davidson S. The use of vitamin B12 in the treatment of diabetic neuropathy. J Flor Med Assoc. 1954;15:717–20.
De Grandis D, Minardi C. Acetyl-L-carnitine (levacecarnine) in the
treatment of diabetic neuropathy. A long-term, randomised,
double-blind, placebo-controlled study. Drugs R D. 2002;3(4):223-31.
Dincer Y, Akcay T, et al. Effect of oxidative stress on glutathione
pathway in red blood cells from patients with insulin-dependent
diabetes mellitus. Metabolism. 2002 Oct;51(10):1360–2.
El-Atat FA, McFarlane SI, et al. Sudden cardiac death in patients with diabetes. Curr Diab Rep. 2004 Jun;4(3):187-93. Review.
Flint H, Cotter MA, et al. Pentoxifylline effects on nerve
conduction velocity and blood flow in diabetic rats. Int J Exp Diabetes
Res. 2000;1(1):49–58.
Franca DS, Souza AL, et al. B vitamins induce an antinociceptive
effect in the acetic acid and formaldehyde models of nociception in
mice. Eur J Pharmacol. 2001 Jun 15;421(3):157–64.
Gerbi A, Maixent JM, et al. Fish oil supplementation prevents
diabetes-induced nerve conduction velocity and neuroanatomical changes
in rats. J Nutr. 1999 Jan;129(1):207–13.
Ghirardi O, Lo Giudice P, et al. Acetyl-L-carnitine prevents and
reverts experimental chronic neurotoxicity induced by oxaliplatin,
without altering its antitumor properties. Anticancer Res. 2005
Jul-Aug;25(4):2681–7.
Halat KM, Dennehy CE. Botanicals and dietary supplements in diabetic
peripheral neuropathy. J Am Board Fam Pract. 2003 Jan-Feb;16(1):47–57.
Haupt E, Ledermann H, et al. Benfotiamine in the treatment of
diabetic polyneuropathy: A three-week randomized, controlled pilot
study (BEDIP study). Int J Clin Pharmacol Ther. 2005 Feb;43(2):71–7.
Horrobin DF. Nutritional and medical importance of gamma-linolenic acid. Prog Lipid Res. 1992a;31(2):163–94.
Horrobin DF. The use of gamma-linolenic acid in diabetic neuropathy. Agents Actions Suppl. 1992b;37:120–44.
Huang YS, Lin X, et al. Effect of dietary linoleic acid content on
the distribution of triacylglycerol molecular species in rat adipose
tissue. Lipids. 1992a Sep;27(9):711–5.
Huang YS, Redden PR, et al. Effects of repeated gestation and
lactation on milk n-6 fatty acid composition in rats fed on a diet rich
in 18:2n-6 or 18:3n-6. Br J Nutr. 1992b Sep;68(2):337–47.
Jacob S, Henriksen EJ, et al. Enhancement of glucose disposal in
patients with type 2 diabetes by alpha-lipoic acid.
Arzneimittelforschung. 1995 Aug;45(8):872–4.
Jacob S, Ruus P, et al. Oral administration of RAC-alpha-lipoic acid
modulates insulin sensitivity in patients with type-2 diabetes
mellitus: a placebo-controlled pilot trial. Free Radic Biol Med. 1999
Aug;27(3-4):309–14.
Jamal GA, Carmichael H. The effect of gamma-linolenic acid on human
diabetic peripheral neuropathy: A double-blind placebo-controlled
trial. Diabet Med. 1990 May;7(4):319–23.
Jones CL, Gonzalez V. Pyridoxine deficiency: A new factor in diabetic neuropathy. J Am Podiatry Assoc. 1978 Sep;68(9):646–53.
Jurna I. Analgesic and analgesia-potentiating action of B vitamins. Schmerz. 1998 Apr 20;12(2):136–41.
Kawabata T, Packer L. Alpha-lipoate can protect against glycation of
serum albumin, but not low density lipoprotein. Biochem Biophys Res
Commun. 1994 Aug 30;203(1):99–104.
Keen H, Payan J, et al. Treatment of diabetic neuropathy with
gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group.
Diabetes Care. 1993 Jan;16(1):8–15.
Khajavi M, Inoue K, et al. Curcumin treatment abrogates endoplasmic
reticulum retention and aggregation-induced apoptosis associated with
neuropathy-causing myelin protein zero-truncating mutants. Am J Hum
Genet. 2005 Nov;77(5):841–50.
Love A, Cotter MA, et al. Effects of the sulphydryl donor
N-acetyl-L-cysteine on nerve conduction, perfusion, maturation and
regeneration following freeze damage in diabetic rats. Eur J Clin
Invest. 1996 Aug;26(8):698–706.
Maestri A, De Pasquale Ceratti A, et al. A pilot study on the effect
of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral
neuropathy. Tumori. 2005 Mar-Apr;91(2):135–8.
Martinello F, Fardin P, et al. Supplemental therapy in isolated
vitamin E deficiency improves the peripheral neuropathy and prevents
the progression of ataxia. J Neurol Sci. 1998 Apr 1;156(2):177–9.
Medina-Santillan R, Morales-Franco G, et al. Treatment of diabetic
neuropathic pain with gabapentin alone or combined with vitamin B
complex: Preliminary results. Proc West Pharmacol Soc. 2004;47:109–12.
Melhem MF, Craven PA, et al. Alpha-lipoic acid attenuates
hyperglycemia and prevents glomerular mesangial matrix expansion in
diabetes. J Am Soc Nephrol. 2002 Jan;13(1):108–16.
Nagamatsu M, Nickander KK, et al. Lipoic acid improves nerve blood
flow, reduces oxidative stress, and improves distal nerve conduction in
experimental diabetic neuropathy. Diabetes Care. 1995 Aug;18(8):1160–7.
Negrisanu G, Rosu M, et al. Effects of 3-month treatment with the
antioxidant alpha-lipoic acid in diabetic peripheral neuropathy. Rom J
Intern Med. 1999 Jul-Sep;37(3):297–306.
Osawa T, Kato Y. Protective role of antioxidative food factors in
oxidative stress caused by hyperglycemia. Ann N Y Acad Sci. 2005
Jun;1043:440–51.
Park SA, Choi KS, et al. Cisplatin-induced apoptotic cell death in
mouse hybrid neurons is blocked by antioxidants through suppression of
cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand. J
Neurochem. 2000 Sep;75(3):946–53.
Sadun AA. Metabolic optic neuropathies. Semin Ophthalmol. 2002 Mar;17(1):29–32.
Sancetta SM, Ayres PR, et al. The use of vitamin B12 in the
management of the neurological manifestations of diabetes mellitus,
with notes on the administration of massive doses. Ann Int Med.
1951;35:1028–48.
Schenker M, Riederer BM, et al. Thyroid hormone reduces the loss of
axotomized sensory neurons in dorsal root ganglia after sciatic nerve
transection in adult rat. Exp Neurol. 2003 Nov;184(1):225–36.
Sima AA, Calvani M, et al. Acetyl-L-carnitine improves pain, nerve
regeneration, and vibratory perception in patients with chronic
diabetic neuropathy: An analysis of two randomized placebo-controlled
trials. Diabetes Care. 2005 Jan;28(1):89–94.
Sinclair AJ, Taylor PB, et al. Low plasma ascorbate levels in
patients with type 2 diabetes mellitus consuming adequate dietary
vitamin C. Diabet Med. 1994 Nov;11(9):893–8.
Solomon LR, Cohen K. Erythrocyte 02 transport and metabolism and
effects of vitamin B6 therapy in type II diabetes mellitus. Diabetes.
1989 Jul;38(7):881–6.
Soneru IL, Khan T, et al. Acetyl-L-carnitine effects on nerve
conduction and glycemic regulation in experimental diabetes. Endocr
Res. 1997 Feb-May;23(1-2):27-36.
Song KH, Lee WJ, et al. Alpha-lipoic acid prevents diabetes mellitus
in diabetes-prone obese rats. Biochem Biophys Res Commun. 2005 Jan
7;326(1):197–202.
Sun Y, Lai MS, et al. Effectiveness of vitamin B12 on diabetic
neuropathy: Systematic review of clinical controlled trials. Acta
Neurol Taiwan. 2005 Jun;14(2):48–54.
Suzuki YJ, Tsuchiya M, et al. Lipoate prevents glucose-induced protein modifications. Free Radic Res Commun. 1992;17(3):211–7.
Tankova T, Cheninkova S, et al. Treatment for diabetic
mononeuropathy with alpha-lipoic acid. Int J Clin Pract. 2005
Jun;59(6):645–50.
Turpeinen AK, Kuikka JT, et al. Long-term effect of
acetyl-L-carnitine on myocardial 123I-MIBG uptake in patients with
diabetes. Clin Auton Res. 2000 Feb;10(1):13-6.
Tutuncu NB, Bayraktar M, et al. Reversal of defective nerve
conduction with vitamin E supplementation in type 2 diabetes: A
preliminary study. Diabetes Care. 1998 Nov;21(11):1915–8.
Voria I, Hauser J, et al. Improved sciatic nerve regeneration by
local thyroid hormone treatment in adult rat is accompanied by
increased expression of SCG10. Exp Neurol. 2006 Jan;197(1):258–67.
Wang YP, Ji L, et al. [Effects of acupuncture on diabetic peripheral neuropathies]. Zhongguo Zhen Jiu. 2005 Aug;25(8):542–4.
Wang ZB, Gan Q, et al. Thiamine, pyridoxine, cyanocobalamin and
their combination inhibit thermal, but not mechanical hyperalgesia in
rats with primary sensory neuron injury. Pain. 2005 Mar;114(1-2):266–77.
Winkler G, Pal B, et al. Effectiveness of different benfotiamine
dosage regimens in the treatment of painful diabetic neuropathy.
Arzneimittelforschung. 1999 Mar;49(3):220–4.
Ziegler D, Gries FA. Alpha-lipoic acid in the treatment of diabetic
peripheral and cardiac autonomic neuropathy. Diabetes. 1997a Sep;46
Suppl 2:S62–S66.
Ziegler D, Schatz H, et al. Effects of treatment with the
antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM
patients: A 4-month randomized controlled multicenter trial (DEKAN
Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care. 1997b
Mar;20(3):369–73.
Ziegler D, Sohr G, et al. Oxidative stress and antioxidant defense
in relation to the severity of diabetic polyneuropathy and
cardiovascular autonomic neuropathy. Diabetes Care. 2004
Sep;27(9):2178–83.
Print
PDF
Email
View Health Concern
